A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Calusterone
Thiopropazate
The risk or severity of adverse effects can be increased when Nabiximols is combined with Thiopropazate.
Calusterone
Moperone
The risk or severity of adverse effects can be increased when Nabiximols is combined with Moperone.
Calusterone
Trifluperidol
The risk or severity of adverse effects can be increased when Nabiximols is combined with Trifluperidol.
Calusterone
Bifemelane
The risk or severity of adverse effects can be increased when Nabiximols is combined with Bifemelane.
Calusterone
Iprazochrome
The risk or severity of adverse effects can be increased when Nabiximols is combined with Iprazochrome.
Calusterone
Gedocarnil
The risk or severity of adverse effects can be increased when Nabiximols is combined with Gedocarnil.
Calusterone
Veralipride
The risk or severity of adverse effects can be increased when Nabiximols is combined with Veralipride.
Calusterone
Mebicar
The risk or severity of adverse effects can be increased when Nabiximols is combined with Mebicar.
Calusterone
Metergoline
The risk or severity of adverse effects can be increased when Nabiximols is combined with Metergoline.
Calusterone
Emepronium
The risk or severity of adverse effects can be increased when Nabiximols is combined with Emepronium.
Calusterone
Iprindole
The risk or severity of adverse effects can be increased when Nabiximols is combined with Iprindole.
Calusterone
Meptazinol
The risk or severity of adverse effects can be increased when Nabiximols is combined with Meptazinol.
Calusterone
Oxaflozane
The risk or severity of adverse effects can be increased when Nabiximols is combined with Oxaflozane.
Calusterone
Phenibut
The risk or severity of adverse effects can be increased when Nabiximols is combined with Phenibut.
Calusterone
Nicomorphine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Nicomorphine.
Calusterone
Medazepam
The risk or severity of adverse effects can be increased when Nabiximols is combined with Medazepam.
Calusterone
Thiazinam
The risk or severity of adverse effects can be increased when Nabiximols is combined with Thiazinam.
Calusterone
Fenyramidol
The risk or severity of adverse effects can be increased when Nabiximols is combined with Fenyramidol.
Calusterone
Lofepramine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Lofepramine.
Calusterone
Oxypertine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Oxypertine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3